SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-060912
Filing Date
2020-12-01
Accepted
2020-12-01 17:06:19
Documents
2
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2182
2 POA DOCUMENT poa.txt EX-24.3_947599 3774
  Complete submission text file 0001209191-20-060912.txt   7381
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Wigginton Jon Marc (Reporting) CIK: 0001587487 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 201361545